Cargando…

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation

SARS-CoV-2 is spreading globally at a rapid pace. To contain its spread and prevent further fatalities, the development of a vaccine against SARS-CoV-2 is an urgent prerequisite. Thus, in this article, by utilizing the in-silico approach, a vaccine candidate for SARS-CoV-2 has been proposed. Moreove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharya, Manojit, Sharma, Ashish Ranjan, Patra, Prasanta, Ghosh, Pratik, Sharma, Garima, Patra, Bidhan Chandra, Saha, Rudra P., Lee, Sang-Soo, Chakraborty, Chiranjib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361115/ https://www.ncbi.nlm.nih.gov/pubmed/32835079 http://dx.doi.org/10.1016/j.imu.2020.100394

Ejemplares similares

Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Evaluation and Designing of Epitopic-Peptide Vaccine Against Bunyamwera orthobunyavirus Using M-Polyprotein Target Sequences
por: Ghosh, Pratik, et al.
Publicado: (2021)

A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics
por: Ghosh, Pratik, et al.
Publicado: (2021)

MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia
por: Chakraborty, Chiranjib, et al.
Publicado: (2016)

A Next-Generation Vaccine Candidate Using Alternative Epitopes to Protect against Wuhan and All Significant Mutant Variants of SARS-CoV-2: An Immunoinformatics Approach
por: Bhattacharya, Manojit, et al.
Publicado: (2021)

Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Response to: Status of Remdesivir: Not Yet Beyond Question!
por: Saha, Abinit, et al.
Publicado: (2021)

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
por: Saha, Abinit, et al.
Publicado: (2020)

Epitope-Based Vaccine Designing of Nocardia asteroides Targeting the Virulence Factor Mce-Family Protein by Immunoinformatics Approach
por: Patra, Prasanta, et al.
Publicado: (2019)

SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Insight into Evolution and Conservation Patterns of B1-Subfamily Members of GPCR
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

MicroRNAs: Possible Regulatory Molecular Switch Controlling the BBB Microenvironment
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

Determination of k-mer density in a DNA sequence and subsequent cluster formation algorithm based on the application of electronic filter
por: Sarkar, Bimal Kumar, et al.
Publicado: (2021)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Integrative Bioinformatics Approaches Indicate a Particular Pattern of Some SARS-CoV-2 and Non-SARS-CoV-2 Proteins
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential
por: Sharma, Ashish Ranjan, et al.
Publicado: (2021)

D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Multi Epitopic Peptide Based Vaccine Development Targeting Immobilization Antigen of Ichthyophthirius multifiliis: A Computational Approach
por: Ghosh, Pratik, et al.
Publicado: (2022)

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

The current second wave and COVID-19 vaccination status in India
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
por: Bhattacharya, Manojit, et al.
Publicado: (2022)

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
por: Saha, Rudra P., et al.
Publicado: (2020)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1flljs15ufn1cr10ceca9an3j3